Madrigal Pharmaceuticals, Inc. Share Price Börse Stuttgart
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
01:26:20 02/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 444.10 EUR | -0.02% |
|
-1.38% | -10.30% |
| 24/09 | Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta, Rollins… |  |
| 23/09 | Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target | MT |
| Market Cap | 1.15TCr 1.03TCr 958.98Cr 873.89Cr 1.65TCr 1,11200Cr 1.67TCr 12TCr 4.49TCr 57TCr 4.33TCr 4.24TCr 1,81800Cr | P/E 2026 * |
-79.5x | P/E 2027 * | 92.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.1TCr 978.87Cr 915.41Cr 834.19Cr 1.57TCr 1,06100Cr 1.59TCr 11TCr 4.29TCr 54TCr 4.14TCr 4.05TCr 1,73600Cr | EV / Sales 2026 * |
7.22x | EV / Sales 2027 * | 4.98x |
| Free-Float |
94.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDGL | Delayed | |
CBOE
| MDGL | Real-time | |
|
Tradegate
| YDO1 | Real-time | |
|
Deutsche Boerse AG
| YDO1 | Delayed | |
|
Börse Stuttgart
| YDO1 | Delayed | |
|
Boerse Muenchen
| YDO1 | Real-time | |
|
Borsa Italiana
| 1MDGL | End-of-day quote | |
|
Xetra
| YDO1 | Delayed |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 week | -1.33% | ||
| Current month | -0.02% | ||
| 1 month | -3.94% | ||
| 3 months | -1.83% | ||
| 6 months | -2.59% | ||
| Current year | -10.32% |
| 1 week | 439.4 |  | 458.8 |
| 1 month | 439.4 | | 471.6 |
| 3 years | 113.8 | | 519.6 |
| 5 years | 48.4 | | 519.6 |
| 10 years | 11.34 | | 519.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.02% | -1.38% | +15.92% | +202.42% | 1.16TCr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.45TCr | |
| -0.61% | +0.69% | +36.36% | +82.72% | 6.01TCr | |
| -2.54% | -0.21% | +6.34% | +31.72% | 4.82TCr | |
| -3.02% | -5.20% | +27.94% | +32.51% | 4.43TCr | |
| +0.31% | +3.02% | +348.95% | +643.82% | 4.4TCr | |
| -1.96% | -0.33% | +7.04% | +99.46% | 4.16TCr | |
| +3.32% | +3.49% | +11.18% | +51.23% | 3TCr | |
| +4.77% | +6.16% | +36.77% | +22.78% | 2.93TCr | |
| -4.86% | -10.66% | -26.27% | +330.06% | 2.49TCr | |
| Average | -0.05% | -0.08% | +51.36% | +159.09% | 4.41TCr | |
| Weighted average by Cap. | +0.17% | +0.11% | +58.74% | +147.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152.74Cr 135.67Cr 126.87Cr 115.61Cr 217.66Cr 15TCr 220.65Cr 1.53TCr 594.15Cr 7.49TCr 573.47Cr 561.04Cr 24TCr | 212.85Cr 189.05Cr 176.8Cr 161.11Cr 303.31Cr 20TCr 307.48Cr 2.14TCr 827.95Cr 10TCr 799.13Cr 781.81Cr 34TCr |
| Net income | -18Cr -16Cr -15Cr -14Cr -26Cr -1.76TCr -26Cr -183.91Cr -71Cr -897.43Cr -69Cr -67Cr -2.88TCr | 18Cr 16Cr 15Cr 14Cr 25Cr 1.72TCr 26Cr 179.79Cr 70Cr 877.33Cr 67Cr 66Cr 2.82TCr |
| Net Debt | -52Cr -47Cr -44Cr -40Cr -75Cr -5.05TCr -76Cr -527.07Cr -204.03Cr -2.57TCr -196.93Cr -192.66Cr -8.26TCr | -94Cr -84Cr -78Cr -71Cr -134.41Cr -9.08TCr -136.26Cr -947.8Cr -366.9Cr -4.63TCr -354.13Cr -346.45Cr -15TCr |
| Date | Price | Change |
|---|---|---|
| 01/26/01 | €444.10 | -0.02% |
| 30/26/30 | €444.20 | -0.54% |
| 29/26/29 | €446.60 | -1.33% |
| 28/26/28 | €452.60 | -0.07% |
| 25/26/25 | €452.90 | +0.62% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
Select your edition
All financial news and data tailored to specific country editions
